Cost-effectiveness of atypical antipsychotics for the bipolar disorder treatment (relapse prevention): The Russian perspective
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: KOMAROV, Iliya (I.M. Sechenov First Moscow State Medical University, Laboratory of Pharmacoeconomics, Moscow, Russian Federation)
- Co-author(s): Kulikov, A. (I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation)
Yagudina, Roza (Moscow Pharmaceutical Society, Moscow, Russian Federation)
Bipolar disorder has a significant impact on the patient[simplequote]s quality of life, imposing a considerable economic burden on the individual, family members and society as a whole. The disease is characterized by episodes of either mania or hypomania alternating with depressive episodes.
: To estimate the efficiency of the.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.